MyAverix Finance
AU · Healthcare
Ordinary Fully Paid Deferred Settlement (CHMDA)
Biotechnology
Ordinary Fully Paid Deferred Settlement (CHMDA) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CHMDA
Ordinary Fully Paid Deferred Settlement (CHMDA) — FAQ
What is CHMDA's P/E ratio?
The price-to-earnings (P/E) ratio for Ordinary Fully Paid Deferred Settlement (CHMDA) is 25.00 (data as of 2026-05-23).
Does Ordinary Fully Paid Deferred Settlement pay a dividend?
Dividend yield is not available in the current snapshot for Ordinary Fully Paid Deferred Settlement (CHMDA). Check the MyAverix Finance app for the latest dividend data.
What sector is Ordinary Fully Paid Deferred Settlement in?
Ordinary Fully Paid Deferred Settlement (CHMDA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CHMDA listed on?
CHMDA is listed on AU.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.